GO:0004126 cytidine deaminase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004126 cytidine deaminase activity catalyzes the hydrolytic deamination of cytidine to uridine and deoxycytidine to deoxyuridine, releasing ammonium.
• The most studied enzyme carrying this activity is activation-induced cytidine deaminase (AID, gene AICDA), which is essential for class switch recombination and somatic hypermutation in B cells.
• AID activity is targeted to specific DNA secondary structures, such as those in BCL2 and MYC, linking cytidine deaminase activity to oncogenic translocations.
• Cytidine deaminase activity is not limited to the immune system; AID regulates activity-dependent BDNF expression in post-mitotic cortical neurons.
• Altered cytidine deaminase activity is implicated in cancer, autoimmune disease, viral infections, and inflammatory joint disease.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise dissection of cytidine deaminase function in health and disease.
Description
Cytidine deaminase activity (GO:0004126) is a fundamental enzymatic function that removes an amino group from cytidine or deoxycytidine, converting them to uridine or deoxyuridine, respectively, and releasing ammonium. This reaction is central to nucleotide metabolism and to the diversification of antibodies. The enzyme activation-induced cytidine deaminase (AID), encoded by AICDA, is the prototypical cytidine deaminase in adaptive immunity, where it initiates class switch recombination and somatic hypermutation. Beyond immunity, cytidine deaminase activity influences neuronal gene expression, viral replication, and cancer development. Researchers study GO:0004126 to understand how targeted DNA and RNA deamination shapes genome stability, immune diversity, and disease pathogenesis.
cytidine deaminase activity At A Glance
| GO ID | GO:0004126 |
|---|---|
| GO term | cytidine deaminase activity |
| Ontology | molecular_function |
| Synonym | cytidine aminohydrolase activity; cytosine nucleoside deaminase activity; (deoxy)cytidine deaminase activity; deoxycytidine deaminase activity |
| Major function | Hydrolytic deamination of cytidine to uridine and deoxycytidine to deoxyuridine, releasing ammonium |
| Representative enzyme | Activation-induced cytidine deaminase (AID/AICDA) |
| Key biological processes | Class switch recombination, somatic hypermutation, neuronal gene regulation, antiviral defense |
| Substrates | Cytidine, deoxycytidine |
| Products | Uridine, deoxyuridine, ammonium |
What Is GO:0004126?
According to the Gene Ontology, cytidine deaminase activity (GO:0004126) is defined as the catalysis of two related reactions: cytidine + H+ + H2O = uridine + NH4, and deoxycytidine + H+ + H2O = deoxyuridine + NH4+. In other words, the enzyme replaces the amino group at the 4-position of the cytosine ring with a hydroxyl group, using water and a proton, and releasing ammonia. This activity is synonymous with cytidine aminohydrolase, cytosine nucleoside deaminase, (deoxy)cytidine deaminase, and deoxycytidine deaminase activity.
Why Is cytidine deaminase activity Important in Cell Biology?
Cytidine deaminase activity is important because it sits at the intersection of nucleic acid metabolism, immune diversification, and disease. AID, the best-characterized enzyme with this activity, is absolutely required for class switch recombination and somatic hypermutation, processes that generate antibody diversity. Dysregulated AID activity can cause mutations in proto-oncogenes such as BCL2 and MYC, contributing to lymphomagenesis. In neurons, AID regulates activity-dependent BDNF expression, linking cytidine deaminase activity to synaptic plasticity. In viral infections, AID can suppress HBV enhancer activity by downregulating FANCE. Moreover, cytidine deaminase activity in synovial fluid correlates with rheumatoid arthritis severity, and inhibition of cytidine deaminase modulates the antiproliferative effects of nucleoside analogs. Thus, understanding GO:0004126 is critical for immunology, neurobiology, oncology, and antiviral research.
• Essential for antibody diversification through class switch recombination and somatic hypermutation.
• Targets DNA secondary structures in BCL2 and MYC, linking activity to oncogenic translocations.
• Regulates activity-dependent BDNF expression in cortical neurons, impacting neuroplasticity.
• Suppresses HBV EnhII/CP activity by downregulating FANCE, revealing antiviral roles.
• Modulates the antiproliferative activity of DMDC, a nucleoside analog, in cancer cells.
• Cytidine deaminase activity in synovial fluid is associated with rheumatoid arthritis and cartilage degradation.
• Implicated in cancer, autoimmune diseases, and inflammatory conditions.
• AID targeting and activity are tightly regulated to prevent off-target mutations.
• Provides a mechanistic basis for CRISPR base editing and gene editing technologies.
• Serves as a biomarker and therapeutic target in hematological malignancies and solid tumors.
What Happens During cytidine deaminase activity?
Substrate recognition and binding
In simple terms: The enzyme finds and grabs its target, a cytidine or deoxycytidine molecule.
Cytidine deaminase enzymes recognize cytidine or deoxycytidine within single-stranded nucleic acids or free nucleosides. AID, for example, binds to single-stranded DNA regions that form during transcription or replication, often at secondary structures such as those found in BCL2 and MYC genes. This binding is sequence- and structure-dependent, ensuring that deamination occurs at specific hotspots.
Catalytic deamination
In simple terms: The enzyme removes an amino group from cytosine, turning it into uracil.
The catalytic mechanism involves a zinc ion coordinated by conserved histidine and cysteine residues. Water is activated to attack the carbon at the 4-position of the cytosine ring, displacing the amino group as ammonium. This converts cytidine to uridine or deoxycytidine to deoxyuridine. The reaction is hydrolytic and requires a proton, as described in the GO definition.
Product release and downstream processing
In simple terms: The newly formed uridine is released and can be used or further processed.
After deamination, uridine or deoxyuridine is released. In DNA, uracil is recognized by uracil DNA glycosylase and processed through base excision repair, leading to mutations or repair. In the context of AID, this process generates uracil:guanine mismatches that are resolved by error-prone repair pathways to produce somatic hypermutation or class switch recombination.
Biological outcomes
In simple terms: The deamination event can change antibody genes, regulate neuronal genes, or affect viruses.
The outcome of cytidine deaminase activity depends on the context. In B cells, AID-mediated deamination of immunoglobulin genes leads to antibody diversification. In neurons, AID regulates activity-dependent BDNF expression, influencing synaptic function. In viral infections, AID can suppress HBV enhancer activity by downregulating FANCE. These diverse outcomes highlight the pleiotropic roles of GO:0004126.
Key Genes Involved in GO:0004126 cytidine deaminase activity
The following genes and proteins are directly associated with cytidine deaminase activity (GO:0004126) or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AICDA | Encodes activation-induced cytidine deaminase (AID), the primary enzyme for class switch recombination and somatic hypermutation | Central to antibody diversification and B-cell lymphomagenesis |
| APOBEC1 | Cytidine deaminase that edits apolipoprotein B mRNA | Model for RNA editing and tissue-specific deamination |
| APOBEC3G | Cytidine deaminase with antiviral activity against HIV | Target for antiviral research and innate immunity |
| CDA | Cytidine deaminase involved in nucleoside metabolism and drug resistance | Modulates sensitivity to cytarabine and other nucleoside analogs |
| BCL2 | Contains DNA secondary structures targeted by AID | Oncogene frequently translocated in lymphoma |
| MYC | Contains DNA secondary structures targeted by AID | Oncogene deregulated in many cancers |
| BDNF | Regulated by AID in neurons | Implicated in neuroplasticity and psychiatric disorders |
| FANCE | Downregulated by AID in HBV infection | Links AID to viral suppression |
| TP53 | Frequently mutated in cancers with aberrant AID activity | Tumor suppressor and AID off-target |
| UNG | Uracil DNA glycosylase that processes AID-induced uracil | Essential for somatic hypermutation and class switch recombination |
| POLH | Error-prone polymerase involved in AID-induced mutagenesis | Contributes to somatic hypermutation |
| LIG4 | Non-homologous end joining factor for class switch recombination | Required for AID-dependent recombination |
| XRCC4 | NHEJ factor for class switch recombination | Works with LIG4 in AID-initiated events |
| CD40 | Costimulatory receptor that induces AID expression | Regulates AID in germinal center B cells |
| IL4 | Cytokine that induces AID and class switching | Drives IgE and IgG1 production |
| NFKB1 | Transcription factor regulating AICDA expression | Links inflammation to AID induction |
| STAT6 | Transcription factor mediating IL4-induced AID expression | Controls class switch recombination |
| SMUG1 | Uracil DNA glycosylase with overlapping function with UNG | Backup for AID-induced uracil removal |
How Is cytidine deaminase activity Regulated?
Cytidine deaminase activity is tightly regulated at multiple levels. AID expression is induced by cytokines such as IL4 and CD40 signaling in B cells, and its targeting to specific DNA regions is controlled by transcription, chromatin structure, and RNA processing. Post-translational modifications, including phosphorylation and ubiquitination, regulate AID stability and nuclear import. In neurons, AID activity is regulated by neuronal activity, linking deamination to synaptic plasticity. Additionally, cytidine deaminase activity can be inhibited by small molecules, as shown by the modulation of DMDC antiproliferative effects. These regulatory layers ensure that deamination occurs at the right time and place, preventing off-target mutations.
cytidine deaminase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AICDA | B-cell lymphoma, autoimmune disease | Aicda knockout mouse; B-cell-specific conditional knockout |
| BCL2 | Follicular lymphoma, translocation t(14;18) | BCL2 knock-in with AID target sites; lymphoma cell lines |
| MYC | Burkitt lymphoma, translocation t(8;14) | MYC overexpression with AID hotspots; mouse models |
| CDA | Cancer drug resistance to cytarabine | CDA knockout or overexpression in leukemia cell lines |
| BDNF | Depression, neuroplasticity disorders | Neuron-specific Aicda knockout; BDNF reporter mice |
Cancer and lymphomagenesis
Aberrant cytidine deaminase activity, particularly from AID, can cause mutations in proto-oncogenes such as BCL2 and MYC, leading to chromosomal translocations and lymphomagenesis. AID is also implicated in the development of various cancers, including B-cell lymphomas and solid tumors, where its off-target activity contributes to genomic instability. Targeting AID or its downstream repair pathways is a potential therapeutic strategy.
Autoimmune and inflammatory diseases
Cytidine deaminase activity in synovial fluid is associated with rheumatoid arthritis, where it correlates with lactoferrin, acidosis, and cartilage proteoglycan release. This suggests that deamination products may serve as biomarkers or contribute to joint inflammation. Dysregulated AID activity can also lead to autoantibody production and autoimmune conditions.
Viral infections
AID can suppress HBV EnhII/CP activity by downregulating FANCE expression, revealing a role for cytidine deaminase activity in antiviral defense. Other APOBEC family members with cytidine deaminase activity restrict viruses such as HIV, but viruses can counteract these enzymes. Understanding these interactions may inform antiviral therapies.
Neurological and psychiatric disorders
AID regulates activity-dependent BDNF expression in post-mitotic cortical neurons, linking cytidine deaminase activity to neuroplasticity. Dysregulation of this process may contribute to psychiatric disorders such as depression or anxiety, although further research is needed.
From cytidine deaminase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does AID loss affect class switch recombination? | Aicda knockout mouse or B-cell-specific conditional knockout |
| Does a point mutation in AID catalytic domain abolish deaminase activity? | Point-mutation knock-in (e.g., H56A, C87S) in AICDA locus |
| Can AID target a specific oncogene? | Knock-in of AID target sequences into BCL2 or MYC loci |
| Where is AID expressed in vivo? | Tagged knock-in (e.g., AID-GFP) for imaging and ChIP |
| Does AID overexpression drive lymphomagenesis? | Transgenic overexpression of AID in B cells |
| What is the role of CDA in drug resistance? | CDA overexpression or knockout in cancer cell lines |
How to Study the cytidine deaminase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC-based deaminase assay | Conversion of cytidine to uridine | Enzyme kinetics and inhibitor screening |
| ChIP-seq | Genome-wide binding sites of AID | Mapping AID targets in B cells |
| RNA-seq | Transcriptome changes and RNA editing | Identifying AID-regulated genes |
| Whole-genome sequencing | C-to-T mutations and translocations | Detecting AID-induced genomic instability |
| Mass spectrometry | Protein interactions and modifications | Identifying AID regulatory complexes |
| Live-cell imaging | Subcellular localization of AID | Studying nuclear import and targeting |
| Flow cytometry | Class switch recombination and surface Ig | Assessing AID function in B cells |
| ELISA | Cytidine deaminase levels in synovial fluid | Rheumatoid arthritis biomarker studies |
Enzymatic activity assays
Cytidine deaminase activity can be measured using spectrophotometric or HPLC-based assays that monitor the conversion of cytidine to uridine or deoxycytidine to deoxyuridine. These assays are used to quantify enzyme kinetics and inhibitor efficacy.
DNA and RNA sequencing
Next-generation sequencing, including RNA-seq and whole-genome sequencing, can identify C-to-U or C-to-T mutations induced by cytidine deaminase activity. AID target sites can be mapped using ChIP-seq or related techniques.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins interacting with AID or other cytidine deaminases, revealing regulatory complexes. Post-translational modifications can also be mapped.
Imaging and reporter assays
Fluorescently tagged AID (e.g., AID-GFP) allows live-cell imaging of nuclear import and targeting. Reporter assays with uracil-sensitive fluorescent proteins can measure deamination in real time.
How CRISPR Can Be Used to Study GO:0004126 cytidine deaminase activity
Knockout
CRISPR knockout of AICDA or other cytidine deaminase genes (e.g., CDA, APOBEC3G) can abolish enzymatic activity, allowing researchers to study loss-of-function phenotypes such as defective class switch recombination or altered drug sensitivity. EDITGENE provides custom knockout cell models in relevant cell types (e.g., B cells, cancer cell lines).
Point Mutation
Point mutations in the catalytic domain of AID (e.g., H56A, C87S) can be introduced using CRISPR base editing or homology-directed repair to dissect the contribution of specific residues to deaminase activity. These models are valuable for understanding structure-function relationships.
Knock-in
Knock-in of AID target sequences (e.g., BCL2 or MYC secondary structures) into a reporter locus allows precise measurement of deamination at defined sites. Alternatively, tagged AID (e.g., AID-GFP) can be knocked in for imaging and ChIP studies.
Overexpression
Overexpression of AID or other cytidine deaminases via CRISPR activation or lentiviral delivery can model gain-of-function phenotypes, such as increased mutagenesis and lymphomagenesis. EDITGENE offers stable overexpression cell lines for functional studies.
How EDITGENE Supports cytidine deaminase activity Research
Researchers studying cytidine deaminase activity-related genes often need to determine whether a candidate gene is causally involved in immune diversification, cancer, or neuronal function. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for cytidine deaminase activity research.
Frequently Asked Questions About cytidine deaminase activity
What is cytidine deaminase activity?
Cytidine deaminase activity (GO:0004126) is the enzymatic catalysis of cytidine to uridine and deoxycytidine to deoxyuridine, releasing ammonium.
What genes are involved in cytidine deaminase activity?
Key genes include AICDA (encoding AID), CDA, APOBEC1, APOBEC3G, and others that carry this enzymatic function.
What is the role of AID in the immune system?
AID is essential for class switch recombination and somatic hypermutation, which generate antibody diversity.
How is cytidine deaminase activity regulated?
It is regulated by cytokines, transcription factors, post-translational modifications, and targeting to specific DNA structures.
What diseases are associated with cytidine deaminase activity?
Dysregulated activity is linked to B-cell lymphomas, autoimmune diseases, viral infections, and rheumatoid arthritis.
Can cytidine deaminase activity be measured in the lab?
Yes, using HPLC-based assays, sequencing, and reporter systems.
What is the difference between AID and APOBEC enzymes?
Both are cytidine deaminases, but AID primarily targets immunoglobulin genes in B cells, while APOBEC enzymes target RNA or viral DNA.
How does AID contribute to cancer?
AID can cause off-target mutations in proto-oncogenes like BCL2 and MYC, leading to translocations and lymphomagenesis.
What CRISPR models are available for studying cytidine deaminase activity?
Knockout, point mutation, knock-in, and overexpression models can be generated for AICDA and related genes.
Why is cytidine deaminase activity important for neurons?
AID regulates activity-dependent BDNF expression in cortical neurons, influencing synaptic plasticity.
Conclusion
Cytidine deaminase activity (GO:0004126) is a critical enzymatic function with far-reaching roles in immunity, neuronal function, and disease. The prototypical enzyme AID exemplifies how targeted deamination can diversify antibodies but also drive oncogenesis when deregulated. Understanding the molecular mechanisms, regulation, and disease associations of cytidine deaminase activity is essential for developing new therapies. EDITGENE's CRISPR services empower researchers to create precise cell models to study this activity and its impact on human health.
References
- 1. Muramatsu M et al.. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.. Cell 102(5):553-63 PMID: 11007474
- 2. Fear DJ. 2013. Mechanisms regulating the targeting and activity of activation induced cytidine deaminase.. Curr Opin Immunol 25(5):619-28 PMID: 24209594
- 3. McCrury M et al.. 2026. DNA secondary structures in BCL2 and MYC elicit activation-induced cytidine deaminase binding and activity.. Nucleic Acids Res 54(5) PMID: 41830329
- 4. Zhou W et al.. 2026. Activation-induced cytidine deaminase (AID) suppresses the activity of HBV EnhII/CP by downregulating FANCE expression.. Virus Genes 62(4):458-469 PMID: 42143639
- 5. Eda H et al.. 1998. The antiproliferative activity of DMDC is modulated by inhibition of cytidine deaminase.. Cancer Res 58(6):1165-9 PMID: 9515801
- 6. Ratnu VS et al.. 2014. Activation-induced cytidine deaminase regulates activity-dependent BDNF expression in post-mitotic cortical neurons.. Eur J Neurosci 40(7):3032-9 PMID: 25041363
- 7. Rios LAS et al.. 2020. Activation-induced cytidine deaminase: in sickness and in health.. J Cancer Res Clin Oncol 146(11):2721-2730 PMID: 32772231
- 8. Månsson B et al.. 1990. Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release.. Ann Rheum Dis 49(8):594-7 PMID: 2396864
